Crossmark

Obtusifolin ameliorates pancreatic tissue injury and inflammation by modulating the NFκB signaling

Published Online: 2026-01-05

Published Print: 2026-02

Authors

Sharma, Nidhi

Walekar, Harshali Santosh

Andugulapati, Sai Balaji
License Information

Text and Data Mining valid from 2026-01-05

Version of Record valid from 2026-01-05
More Information

Article History

Received: 28 May 2025

Accepted: 11 December 2025

First Online: 5 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current